Company record
ADMA Biologics develops and manufactures specialty plasma‑derived biologic therapies, including human immune globulin and Hepatitis B immune globulin. The company also provides contract development and manufacturing (CDMO) services that draw on its capabilities in plasma collection, fractionation, purification, and fill‑finish operations. Its product portfolio and services support healthcare providers and institutions that treat patients with primary immune deficiencies or infectious diseases. All offerings are FDA approved.
This directory record does not yet have a linked material-flow brief.